标普和纳斯达克内在价值 联系我们

SciSparc Ltd. SPRC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

SciSparc Ltd. (SPRC) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $0.03 和 营收为 $6.97B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-1.08 vs 预期 $0.03 (不及预期 -3655%). 分析师准确度: 0%.

EPS 预测 — SPRC

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$1.08 vs Est $0.03 ▼ 102.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

营收预测 — SPRC

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.001B vs Est $6.972B ▼ 533,750.9% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言